Navigation Links
Nycomed, a Takeda Company, Launches Omnaris® Nasal Spray in the UAE for the Treatment of Allergic Rhinitis
Date:3/14/2012

n the BRIC countries and 18th in Europe.

About Takeda

As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, http://www.takeda.com.

This press release has been issued by Nycomed, a Takeda Company, Dubai Airport Free Zone, West Wing 3 - Office 519, P.O. 293 655, Dubai, United Arab Emirates.

1. Chervinsky P, Kunjibettu S, Miller DL, Prenner BM, et al. Long-term safety and e_cacy of ciclesonide in adult and adolescent patients with perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2007;99:69-76

2. Patel P, Patel D, Kunjibettu S, Hall N, et al. Onset of Action of Ciclesonide Once Daily in the Treatment of Seasonal Allergic Rhinitis. ENT J. 2008;87:340-353.

3. Pawankar, Ruby et al. "Special Article. Allergic Rhinitis and Its Impact on Asthma Update (ARIA 2008) - Western and Asian-Pacific Perspective. Asian Pacific Journal of Allergy and Immunology (2009) 27:237-243.

4. AMEInfo.com, 'One third of adults in UAE suffer from allergic rhinitis'. March 17, 2010. http://www.ameinfo.com/226995.html. (Accessed December 2011)



'/>"/>
SOURCE Takeda
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Takeda and Zinfandel Pharmaceuticals Sign Licensing Agreement for Alzheimers Disease Biomarker in Combination with Pioglitazone
2. FDA Continues Review of Takedas New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes
3. Takeda San Francisco, Inc. Appoints Gregory Landes, Ph.D. Vice President of Antibody Research
4. Synthetic Genomics Inc. and Plenus, S.A. de C.V. Form New Sustainable Agriculture Company, Agradis, Inc. to Develop and Commercialize Products Using Genomic Technologies
5. Poplar Healthcare Forms Parent Company, Launches New Web Site
6. CorCell, a Cord Blood America Company, Launches Referral Rewards Program
7. BioCells, Inc., a Cord Blood America Company, to Begin Storing Dental Pulp Stem Cells in Argentina
8. New Oral Biologics Delivery Company, Entrega, Announces Strategic Partnership with Pharma
9. Alexandria Real Estate Equities, Inc. Signs Biopharmaceutical Company, Lilly, as Anchor New York City Tenant at the Alexandria Center for Science and Technology
10. Biotechnology Company, Replikins Ltd., Provided Advance Warning of Mexican H1N1 Swine Flu Virus Outbreak
11. LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... quarter ended June 30, 2015. Amounts, unless specified ... under International Financial Reporting Standards ("IFRS"). ... Oral Amp B program, rapidly advancing towards the ... Rae , President & CEO of iCo Therapeutics. "We ...
(Date:8/26/2015)... , Aug. 26, 2015 Intrexon Corporation (NYSE: ... today the closing of its previously announced public offering ... the underwriters of their option to purchase an additional ... price of $41.00 per share.  The exercise of the ... common stock sold by Intrexon to 5,609,756 shares and ...
(Date:8/26/2015)... ... 2015 , ... PRC Clinical, a Clinical Trial Management Expert CRO, ... in southern California. The Clinical Trial Management Expert CRO seeks to introduce more California-based ... , Stem Cell Meeting on the Mesa on October ...
(Date:8/25/2015)... DIEGO , Aug. 25, 2015 Human Longevity, ... Mark A. Winham has joined the company as Chief ... life sciences, medical operations and technical experience, will report directly ... In this new role as COO, Winham will ... pipeline operations as well as all facility operations. HLI currently ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 4PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3Human Longevity, Inc. Hires Life Sciences Leader, Mark Winham, as Chief Operating Officer 2
... of African American Celebs Join Obama in Knowing their Roots in ... of African descent spawn trend in African Americans to trace roots ... ... DC (PRWEB) November 27, 2008 -- One thing President-Elect Barack Obama ...
... sailing a spacecraft by the optical force of the sun,s light. ... the oversized sails that have been tried. Now a team led ... Science has shown that the force of light indeed can ... to nano-proportions. , Their work opens the door to a ...
... must-have gift , ... New York, NY(PRWEB) November 26, 2008 --DNA 11, ... launch DNA Mini Portraits™, a more affordable line of DNA Art that ... most personal and unique gifting solution for this holiday season that are ...
Cached Biology Technology:Growing Interest in DNA-Based Genetic Testing Among African American with Historic Election of President Elect Barack Obama 2Growing Interest in DNA-Based Genetic Testing Among African American with Historic Election of President Elect Barack Obama 3'The photon force is with us': Harnessing light to drive nanomachines 2DNA 11, Creators of DNA Art, Introduces a More Affordable Line of Custom Portraits for this Year's Gift Giving Season 2
(Date:8/20/2015)... PLEASANTON, Calif. , Aug. 20, 2015 /PRNewswire/ ... focused on consumers that are active and healthy. ... used in the hospital environment to help improve ... released a video from the Wearable Technologies ... MD discussed new applications for wearables in healthcare.    ...
(Date:8/19/2015)... 19, 2015  VOXX International Corporation (Nasdaq: ... into a Definitive Agreement to purchase the assets, ... market leader EyeLock through an acquiring entity.  Upon ... controlling interest in the acquiring entity. The closing ... due diligence.  Expanding on its existing supply chain ...
(Date:8/17/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... Q4 2015. The new marketing campaign is being spearheaded ... Marketing Group ( http://amplitudemarketing.com/ ) and TPMG ( http://tmpg.com/ ... in retail driven marketing and brand awareness and has ...
Breaking Biology News(10 mins):Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 2NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 3
... test to detect whether a person might develop Alzheimer,s ... in their quest toward reversing the disease,s onset in ... Building on a study that started 20 years ago ... or in various stages of developing Alzheimer,s disease, the ...
... paper by a team of researchers led by Shahriar ... University of Notre Dame, provides important new insights into ... The cell wall is a critically important entity ... a rigid entity encasing the bacterium, and antibiotics are ...
... Boulder team working at 16,400 feet in the Peruvian ... glacier ice can swiftly establish a thriving community of ... plants. The discovery is the first to reveal ... of the most extreme environments on Earth and has ...
Cached Biology News:Researchers seeking to identify Alzheimer's risk focus on specific blood biomarker 2As Andean glacier retreats, tiny life forms swiftly move in, CU-Boulder study shows 2As Andean glacier retreats, tiny life forms swiftly move in, CU-Boulder study shows 3
High-throughput DNA preparation and end sequencing of BAC libraries. 3730xl DNA sequencers. LIMS tracking utilizing Geospiza's Finch system. Full-length BAC sequencing also available. Our expertise h...
... DNA sequencing is the experimental process ... DNA region. The automated DNA Sequencing is ... thermostable DNA polymerase, which allows cycle sequencing ... and detected in a capillary instrument controlled ...
... The antibody is preadsorbed to remove any reactivity ... buffered aqueous glycerol solution A solution in ... and Ca 2+ ), pH 7.3 (+/- ... protease free) and 0.05% sodium azide A synthetic ...
... The Bio-Plex maintenance, calibration, ... a custom 96-well plate used ... and calibration procedures using the ... MCV plate is for use ...
Biology Products: